Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsored by: |
Teikoku Pharma USA |
---|---|
Information provided by: | Teikoku Pharma USA |
ClinicalTrials.gov Identifier: | NCT00234728 |
The purpose of this study is to determine if a new dressing designed to be used with topical medications will enhance the effects of these topical medications.
Condition | Intervention |
---|---|
Psoriasis |
Device: Occlusive dressing |
Study Type: | Interventional |
Study Design: | Treatment, Non-Randomized, Open Label, Active Control, Single Group Assignment, Efficacy Study |
Official Title: | An Open-Label, Bilaterally-Controlled Single Center Study to Compare the Efficacy of Occlusion of Topical Agents With a Hydrophilic Occlusive Dressing to Treatment With Occlusive Dressing Without the Addition of Topical Agents |
Estimated Enrollment: | 120 |
Study Start Date: | September 2005 |
Study Completion Date: | June 2007 |
Ages Eligible for Study: | 18 Years and older |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
Exclusion Criteria:
United States, California | |
UCSF Psoriasis and Skin Treatment Center | |
San Francisco, California, United States, 94118 |
Principal Investigator: | John Koo, MD | University of California, San Francisco |
Study ID Numbers: | TPU-2005-02 |
Study First Received: | October 5, 2005 |
Last Updated: | June 30, 2008 |
ClinicalTrials.gov Identifier: | NCT00234728 |
Health Authority: | United States: Institutional Review Board |
psoriasis hydrogel occlusive dressing occlusion hydrocortisone tacrolimus |
Protopic triamcinolone calcipotriene Dovonex halobetasol Ultravate |
Hydrocortisone Skin Diseases Cortisol succinate Triamcinolone diacetate Tacrolimus Triamcinolone hexacetonide Halobetasol |
Calcipotriene Triamcinolone Acetonide Psoriasis Triamcinolone Hydrocortisone acetate Skin Diseases, Papulosquamous |